• IM Residency Doctor's Dilemma Sign-Up

  • To confirm your Internal Medicine Residency's Spot in the 2026 Doctor's Dilemma Competition, please sign-up below.

    Eligibility:

    • All Texas IM Residency programs are invited to participate 
    • Each program must submit 10 Doctor's Dilemma questions as part of their application (may be categorical or random) 
    • Each program is requested to submit one volunteer to assist as an event judge 
    • Team Members (3) must be current TXACP members to compete 
    • Review and agree to the chapter's Doctor's Dilemma rules 

    Membership in the college for residents is $130/annually and registration is available online at https://www.acponline.org/membership/residents. 

    All Team Members must also register for the TXACP Annnual Meeting by October 25th.

    Key Dates:

    • September 21st: All teams must be submitted
    • Tuesday October 13th - Virtual Preliminary Rounds 
    • Saturday, November 14th, 6:00PM: Championship Doctor's Dilemma will be held in Plano
    • April 15-17, 2027: Doctor's Dilemma will be held at ACP IMM in Los Angeles, CA (TBD- The winning Texas team may have an opportunity to represent Texas at the National Competition).
  • Residency Program Requesting Slot:

  • Team Registration

    Please update your team members, include first and last names and credentials
  • Question Format Example and Upload

  • Category Suggestions for Question Creation:

    • Allergy and Immunology (AI) 
    • Biostatistics and Epidemiology (BE)
    • Cardiovascular Medicine (V)
    • Critical Care (CC)
    • Dermatology (DM)
    • Ear, Nose, and Throat (ENT)
    • Endocrinology and Metabolism (EM)
    • Ethics and Professionalism (EP)
    • Gastroenterology and Hepatology (GI)
    • Genetics and Genomics (GN)
    • Geriatrics (GER)
    • Hematology (HM)
    • History of Medicine (HM)
    • Infectious Disease
    • Men's Health
    • Nephrology (NP)
    • Neurology (NR)
    • Oncology (ON)
    • Opthalmology (OP)
    • Pharmacology (PH)
    • Pulmonary Medicine (PM)
    • Rheumatology (RM)
    • Psychiatry (PSY)
    • Travel Medicine
    • Women's Health (WH)

    Example Questions:

    Question #1: This protein is low or deficient in Type I hereditary angiodema.

    Answer: What is C1 inhibitor protein?

    Fun Fact: Cinryze, a pharmaceutical grade C1 inhibitor, was approved for HAI in the U.S. in 2008 after having been available in Europe for decades. 

    Source: Cinryze. U.S. Food and Drug Administration. 12 July 2017. Archived from original on 22 July 2017. Retrieved 20 April 2020.

     

    Question #2: This disease is caused by a deficit in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and involves recurrent bacterial and fungal infections.

    Answer: What is chronic granulomatous disease?

    Fun Fact: It is also known as Bridges-Good syndrome and Quie Syndrome. Difficulty forming the reactive oxygen compounds (most importantly the superoxide radical due to defective phagocyte NADPH oxidase) leads to granuloma formation.

    Source: Heyworth, PG, Cross, AR, Curnette, JT. October 2023. Chronic granulomatous disease. Current opinion in Immunology. 15 (5): 578-84.

  • Browse Files
    Cancelof
  • Should be Empty: